Tarceva and Milk thistle drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tarceva (erlotinib hydrochloride) and Milk thistle (milk thistle). Common drug interactions include dysphonia among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Tarceva and Milk thistle. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Tarceva?

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.

What is Milk thistle?

Milk thistle has active ingredients of milk thistle. It is often used in fatty liver. eHealthMe is studying from 5,057 Milk thistle users. Check the latest studies of Milk thistle.

On Jul, 21, 2026

19 people who take Tarceva and Milk thistle together, and have interactions are studied.

Tarceva and Milk thistle drug interactions.

What are the common drug interactions of Tarceva and Milk Thistle, by gender? *:

female:

Dysphonia (speech disorder attributable to a disorder of phonation)
Hand fracture
Muscle spasms (muscle contraction)
Pain
Tooth disorder (tooth disease)
Trichorrhexis (a condition in which the hairs break)
Weight increased
Cerebral disorder (brain disease)
Localised infection (infection at the single location)
Mass

male:

Death
Fatigue (feeling of tiredness)
Rash
Rib fracture
Skin ulcer
Sunburn
Adverse drug reaction
Blood urine present
Chest pain
Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)

What are the common drug interactions of Tarceva and Milk Thistle, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dysphonia (speech disorder attributable to a disorder of phonation)
Hand fracture
Muscle spasms (muscle contraction)
Pain
Tooth disorder (tooth disease)
Trichorrhexis (a condition in which the hairs break)
Weight increased
Cerebral disorder (brain disease)
Localised infection (infection at the single location)
Mass

50-59:

Death

60+:

Death
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Vomiting
Adverse drug reaction
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Peripheral swelling
Pruritus (severe itching of the skin)
Rib fracture
Skin ulcer

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 7 people, 36.84%
Neoplasm Malignant (cancer tumour): 6 people, 31.58%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 5 people, 26.32%
Lung Carcinoma Cell Type Unspecified Stage I (the lung cancer is small and hasn't spread to the lymph nodes): 5 people, 26.32%
Metastases To Bone (cancer spreads to bone): 5 people, 26.32%
Muscle Spasms (muscle contraction): 5 people, 26.32%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 5 people, 26.32%
Vestibular Disorder (disorders of the body's balance (vestibular) system in the inner ear): 5 people, 26.32%
Panic Disorder: 5 people, 26.32%
Tinnitus (a ringing in the ears): 5 people, 26.32%

* Approximation only. Some reports may have incomplete information.

Do you take Tarceva and Milk thistle?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously